Search

Search bills, members, committees and pages...

LYMPHOMA RESEARCH FOUNDATION

17 federal lobbying filings, 2023 to 2026.

LYMPHOMA RESEARCH FOUNDATION is a client on 17 federal lobbying filings, 2023 to 2026. Based in New York.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

2 it has hired, by filings.

RegistrantFilingsReported
TURNER & GOSS LLP14
LYMPHOMA RESEARCH FOUNDATION3

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262
20254
20244
20237

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues6

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 8839Lainie Jones Comprehensive Cancer Survivorship Act of 20261

Lobbyists

Named on the filings.

LobbyistClientsFilings
ELIZABETH GOSS16

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
LYMPHOMA RESEARCH FOUNDATIONTURNER & GOSS LLP2026 second_quarterJul 19, 2026
LYMPHOMA RESEARCH FOUNDATIONTURNER & GOSS LLP2026 first_quarterApr 19, 2026
LYMPHOMA RESEARCH FOUNDATIONTURNER & GOSS LLP2025 fourth_quarterJan 19, 2026
LYMPHOMA RESEARCH FOUNDATIONTURNER & GOSS LLP2025 third_quarterOct 16, 2025
LYMPHOMA RESEARCH FOUNDATIONTURNER & GOSS LLP2025 second_quarterJul 17, 2025
LYMPHOMA RESEARCH FOUNDATIONTURNER & GOSS LLP2025 first_quarterApr 16, 2025
LYMPHOMA RESEARCH FOUNDATIONTURNER & GOSS LLP2024 fourth_quarterJan 20, 2025
LYMPHOMA RESEARCH FOUNDATIONTURNER & GOSS LLP2024 third_quarterOct 17, 2024
LYMPHOMA RESEARCH FOUNDATIONTURNER & GOSS LLP2024 second_quarterJul 15, 2024
LYMPHOMA RESEARCH FOUNDATIONTURNER & GOSS LLP2024 first_quarterApr 17, 2024
LYMPHOMA RESEARCH FOUNDATIONTURNER & GOSS LLP2023 fourth_quarterJan 18, 2024
LYMPHOMA RESEARCH FOUNDATIONTURNER & GOSS LLP2023 third_quarterOct 19, 2023
LYMPHOMA RESEARCH FOUNDATIONTURNER & GOSS LLP2023 second_quarterJul 19, 2023
LYMPHOMA RESEARCH FOUNDATIONLYMPHOMA RESEARCH FOUNDATION2023 second_quarterJul 14, 2023
LYMPHOMA RESEARCH FOUNDATIONLYMPHOMA RESEARCH FOUNDATION2023 second_quarterJul 14, 2023
LYMPHOMA RESEARCH FOUNDATIONTURNER & GOSS LLP2023 first_quarterApr 19, 2023
LYMPHOMA RESEARCH FOUNDATIONLYMPHOMA RESEARCH FOUNDATION2023 first_quarterApr 17, 2023